We are live on ! Find out more
ALNY icon

Alnylam Pharmaceuticals
ALNY

292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 34

37% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 83

4% more funds holding

Funds holding: 282 → 292 (+10)

3% more call options, than puts

Call options by funds: $109M | Put options by funds: $105M

2.24% less ownership

Funds ownership: 93.75% → 91.51% (-2.2%)

7% less capital invested

Capital invested by funds: $11.7B → $10.9B (-$792M)

14% less funds holding in top 10

Funds holding in top 10: 14 → 12 (-2)

Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.69%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$106M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$54.2M
3
FCM
Farallon Capital Management
California
+$47.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$43.3M
5
O
OrbiMed
New York
+$41.8M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$456M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$35.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$29.4M
4
Goldman Sachs
Goldman Sachs
New York
-$22.8M
5
LCM
Laurion Capital Management
New York
-$15.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$56.2M -$365K -2,833 -0.6%
Deutsche Bank
27
Deutsche Bank
Germany
$53.2M +$30.4M +235,543 +112%
PC
28
Polar Capital
United Kingdom
$52.6M -$9.67M -75,000 -15%
Federated Hermes
29
Federated Hermes
Pennsylvania
$47.8M -$29.4M -228,037 -36%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$47.4M +$392K +3,044 +0.8%
SPC
31
Slate Path Capital
New York
$44.7M -$9.28M -72,000 -16%
FCM
32
Farallon Capital Management
California
$44.1M +$47.7M +370,000 New
Two Sigma Advisers
33
Two Sigma Advisers
New York
$42.5M +$32M +248,200 +228%
Legal & General Group
34
Legal & General Group
United Kingdom
$41.5M +$31.2M +242,098 +227%
CS
35
Credit Suisse
Switzerland
$37.2M +$11.2M +86,693 +38%
Lord, Abbett & Co
36
Lord, Abbett & Co
New Jersey
$35.4M +$5.21M +40,408 +16%
Swiss National Bank
37
Swiss National Bank
Switzerland
$33.7M -$5.62M -43,600 -13%
Charles Schwab
38
Charles Schwab
California
$33M +$1.93M +14,936 +6%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$32.3M -$214K -1,659 -0.6%
Two Sigma Investments
40
Two Sigma Investments
New York
$30.5M -$5.93M -46,000 -15%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$30.4M +$1.98M +15,369 +6%
CC
42
Casdin Capital
New York
$29.8M +$6.45M +50,000 +25%
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
$29.5M +$31.9M +247,754 New
RI
44
RTW Investments
New York
$29.3M -$14.5M -112,545 -31%
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
$28.6M -$6.45M -50,000 -17%
Renaissance Technologies
46
Renaissance Technologies
New York
$28M +$29.3M +227,300 +2,806%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$26M +$2.91M +22,561 +12%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$25.7M -$206K -1,600 -0.7%
KCM
49
Kornitzer Capital Management
Kansas
$25.5M +$304K +2,360 +1%
T
50
TOBAM
France
$24.9M +$12.6M +97,895 +88%
1
2
3 4 5

ALNY Hedge Fund Activity: Q1 2018 in Review

292 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Alnylam Pharmaceuticals (ALNY) for Q1 2018, worth a combined $10.9B — down 6.8% from $11.7B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new ALNY positions and 34 closed out — a net gain of 13 holders — while 114 added to existing stakes and 83 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $106M. The largest seller was Dodge & Cox, cutting an estimated $456M.

  • 292 institutional investors held Alnylam Pharmaceuticals (ALNY) as of Q1 2018, up from 282 in Q4 2017.
  • Funds reported $10.9B of Alnylam Pharmaceuticals stock for Q1 2018, down 6.8% quarter-over-quarter.
  • 47 funds opened new Alnylam Pharmaceuticals positions in Q1 2018 and 34 closed out, a net change of +13 holders.
  • The largest Alnylam Pharmaceuticals buyer in Q1 2018 was Point72 Asset Management, an estimated $106M added.
  • The largest Alnylam Pharmaceuticals seller in Q1 2018 was Dodge & Cox, an estimated $456M sold.

Based on aggregated 13F filings for Q1 2018.